Description
Nanox Bio CJC-1295 is a premium peptide research formulation containing CJC-1295, a synthetic Growth Hormone-Releasing Hormone (GHRH) analog extensively investigated for its role in growth hormone physiology, pituitary signaling, IGF-1 regulation, endocrine biology, and molecular endocrinology. Developed exclusively for laboratory research, CJC-1295 has become an important investigational peptide in studies involving growth hormone secretion, receptor pharmacology, peptide signaling, and metabolic physiology.
By selectively interacting with the Growth Hormone-Releasing Hormone Receptor (GHRH-R) located in the anterior pituitary, CJC-1295 enables researchers to investigate growth hormone release, JAK-STAT signaling, IGF-1 production, endocrine feedback mechanisms, peptide-receptor interactions, and intracellular communication. Its well-characterized pharmacological profile has established it as a valuable research peptide for advanced endocrine and metabolic investigations.
Each package contains 10 sterile vials, with 2 mg of CJC-1295 per vial, manufactured by Nanox Bio under stringent pharmaceutical-quality standards. Every batch undergoes comprehensive quality testing to ensure exceptional purity, peptide integrity, and dependable laboratory performance.
Key Features
- Premium CJC-1295 peptide research formulation
- 2 mg per vial
- 10 sterile vials per package
- Synthetic Growth Hormone-Releasing Hormone (GHRH) analog
- High-purity laboratory-grade peptide
- Extensively researched in growth hormone physiology and endocrine biology
- Suitable for investigations involving GHRH receptor signaling, growth hormone secretion, IGF-1 regulation, peptide pharmacology, intracellular signaling, metabolic physiology, and molecular endocrinology
- Manufactured under rigorous pharmaceutical-quality standards
- Intended exclusively for laboratory and scientific research applications
How It Works
CJC-1295 selectively binds to the Growth Hormone-Releasing Hormone Receptor (GHRH-R) on pituitary somatotroph cells, stimulating intracellular signaling pathways associated with growth hormone secretion and endocrine regulation. Researchers utilize this mechanism to investigate growth hormone physiology, IGF-1 production, receptor pharmacology, peptide signaling, and metabolic communication.
In laboratory studies, CJC-1295 is extensively used to examine GHRH receptor activation, peptide-receptor interactions, endocrine feedback mechanisms, JAK-STAT signaling, pituitary physiology, cellular signaling pathways, and molecular endocrinology. Its unique biological activity continues to make it one of the most widely researched peptides in endocrine and peptide science.
This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.
Contents
Active Ingredient (Per Vial):
- CJC-1295 – 2 mg
Packaging: 10 Sterile Vials
Reviews
There are no reviews yet.